Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)

Osteoarthritis and Cartilage

Volumn 21, Issue 1, 2013, Pages 16-21

  Berenbaum, F ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Adipokines; Cytokines; Inflammaging; Inflammation; Innate immunity; Low grade inflammation; Metabolic syndrome; Obesity; Osteoarthritis; Synovitis

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PROSTAGLANDIN; TUMOR NECROSIS FACTOR INHIBITOR;

AGING; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CLINICAL FEATURE; DISEASE ACTIVITY; ENZYME SYNTHESIS; HUMAN; INFLAMMATORY DISEASE; INNATE IMMUNITY; METABOLIC SYNDROME X; MOLECULAR BIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SUBCHONDRAL BONE PLATE; SYNOVITIS; SYNOVIUM;

ANIMALS; BONE AND BONES; CARTILAGE, ARTICULAR; CHONDROCYTES; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MICE; OSTEOARTHRITIS; SYNOVITIS;

EID: 84871921917     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.11.012     Document Type: Review

References (78)

1. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.-P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011 Jan, 7(1):33-42.
2. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012 Jun, 64(6):1697-1707.
3. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011 Sep, 23(5):471-478.
4. Bijlsma J.W.J., Berenbaum F., Lafeber F.P.J.G. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011 Jun 18, 377(9783):2115-2126.
5. Sellam J., Berenbaum F. Clinical features of osteoarthritis. Kelley's Textbook of Rheumatology 2008, 1547-1561. Elsevier Inc, Philadelphia. G.S. Firestein, R.C. Budd, E.D. Harris, I.B. McInnes, S. Ruddy, J.S. Sergent (Eds.).
6. Shibakawa A., Aoki H., Masuko-Hongo K., Kato T., Tanaka M., Nishioka K., et al. Presence of pannus-like tissue on osteoarthritic cartilage and its histological character. Osteoarthritis Cartilage 2003 Feb, 11(2):133-140.
7. Guermazi A., Roemer F.W., Hayashi D. Imaging of osteoarthritis: update from a radiological perspective. Curr Opin Rheumatol 2011 Sep, 23(5):484-491.
8. Roemer F.W., Guermazi A., Felson D.T., Niu J., Nevitt M.C., Crema M.D., et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis 2011 Oct, 70(10):1804-1809.
9. Ayral X., Pickering E.H., Woodworth T.G., Mackillop N., Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 2005 May, 13(5):361-367.
10. Stürmer T., Brenner H., Koenig W., Günther K.-P. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 2004 Feb, 63(2):200-205.
11. Pearle A.D., Scanzello C.R., George S., Mandl L.A., DiCarlo E.F., Peterson M., et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007 May, 15(5):516-523.
12. Scanzello C.R., McKeon B., Swaim B.H., DiCarlo E., Asomugha E.U., Kanda V., et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum 2011 Feb, 63(2):391-400.
13. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010 Nov, 6(11):625-635.
14. Hussein M.R., Fathi N.A., El-Din A.M.E., Hassan H.I., Abdullah F., Al-Hakeem E., et al. Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol Oncol Res 2008 Sep, 14(3):321-328.
15. Blom A.B., van Lent P.L., Libregts S., Holthuysen A.E., van der Kraan P.M., van Rooijen N., et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007 Jan, 56(1):147-157.
16. Blom A.B., van Lent P.L.E.M., Holthuysen A.E.M., van der Kraan P.M., Roth J., van Rooijen N., et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2004 Aug, 12(8):627-635.
17. Mapp P.I., Walsh D.A. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012 Jul, 8(7):390-398.
18. Haywood L., McWilliams D.F., Pearson C.I., Gill S.E., Ganesan A., Wilson D., et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003 Aug, 48(8):2173-2177.
19. E X., Cao Y., Meng H., Qi Y., Du G., Xu J., et al. Dendritic cells of synovium in experimental model of osteoarthritis of rabbits. Cell Physiol Biochem 2012, 30(1):23-32.
20. Suurmond J., Dorjée A.L., Boon M.R., Knol E.F., Huizinga T.W.J., Toes R.E.M., et al. Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Res Ther 2011, 13(5):R150.
21. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002 Dec 27, 111(7):927-930.
22. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010 May, 11(5):373-384.
23. Kim H.A., Cho M.-L., Choi H.Y., Yoon C.S., Jhun J.Y., Oh H.J., et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 2006 Jul, 54(7):2152-2163.
24. Scanzello C.R., Plaas A., Crow M.K. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?. Curr Opin Rheumatol 2008 Sep, 20(5):565-572.
25. García-Arnandis I., Guillén M.I., Gomar F., Pelletier J.-P., Martel-Pelletier J., Alcaraz M.J. High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther 2010, 12(4):R165.
26. van Lent P.L.E.M., Blom A.B., Schelbergen R.F.P., Slöetjes A., Lafeber F.P.J.G., Lems W.F., et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum 2012 May, 64(5):1466-1476.
27. Sohn D.H., Sokolove J., Sharpe O., Erhart J.C., Chandra P.E., Lahey L.J., et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther 2012, 14(1):R7.
28. Nair A., Kanda V., Bush-Joseph C., Verma N., Chubinskaya S., Mikecz K., et al. Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14. Arthritis Rheum 2012 Jul, 64(7):2268-2277.
29. Scanzello C.R., Umoh E., Pessler F., Diaz-Torne C., Miles T., Dicarlo E., et al. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage 2009 Aug, 17(8):1040-1048.
30. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011 Dec, 17(12):1674-1679.
31. Rosenthal A.K. Crystals, inflammation, and osteoarthritis. Curr Opin Rheumatol 2011 Mar, 23(2):170-173.
32. MacMullan P., McMahon G., McCarthy G. Detection of basic calcium phosphate crystals in osteoarthritis. Joint Bone Spine 2011 Jul, 78(4):358-363.
33. Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006 Mar 9, 440(7081):237-241.
34. Denoble A.E., Huffman K.M., Stabler T.V., Kelly S.J., Hershfield M.S., McDaniel G.E., et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci USA 2011 Feb 1, 108(5):2088-2093.
35. Bougault C., Gosset M., Houard X., Salvat C., Godmann L., Pap T., et al. Stress-induced cartilage degradation does not depend on NLRP3 inflammasome in osteoarthritis. Arthritis Rheum 2012 Aug 29, [Epub ahead of print]. 10.1002/art.34678.
36. Attur M., Statnikov A., Aliferis C.F., Li Z., Krasnokutsky S., Samuels J., et al. Inflammatory genomic and plasma biomarkers predict progression of symptomatic knee OA (SKOA). Osteoarthritis Cartilage 2012 Apr 20, Suppl 1:S34-S35.
37. Fernández-Puente P., Mateos J., Fernández-Costa C., Oreiro N., Fernández-López C., Ruiz-Romero C., et al. Identification of a panel of novel serum osteoarthritis biomarkers. J Proteome Res 2011 Nov 4, 10(11):5095-5101.
38. Attur M., Belitskaya-Lévy I., Oh C., Krasnokutsky S., Greenberg J., Samuels J., et al. Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum 2011 Jul, 63(7):1908-1917.
39. Yusuf E., Nelissen R.G., Ioan-Facsinay A., Stojanovic-Susulic V., DeGroot J., van Osch G., et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 2010 Apr, 69(4):761-765.
40. Pottie P., Presle N., Terlain B., Netter P., Mainard D., Berenbaum F. Obesity and osteoarthritis: more complex than predicted!. Ann Rheum Dis 2006 Nov 1, 65(11):1403-1405.
41. Gabay O., Berenbaum F. Adipokines in arthritis: new kids on the block. Curr Rheumatol Rev 2009, 5(4):226-232.
42. Gómez R., Conde J., Scotece M., Gómez-Reino J.J., Lago F., Gualillo O. What's new in our understanding of the role of adipokines in rheumatic diseases?. Nat Rev Rheumatol 2011 Sep, 7(9):528-536.
43. Gosset M., Berenbaum F., Salvat C., Sautet A., Pigenet A., Tahiri K., et al. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 2008 May, 58(5):1399-1409.
44. Puenpatom R.A., Victor T.W. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 2009 Nov, 121(6):9-20.
45. Sowers M., Karvonen-Gutierrez C.A., Palmieri-Smith R., Jacobson J.A., Jiang Y., Ashton-Miller J.A. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum 2009 Oct 15, 61(10):1328-1336.
46. Yoshimura N., Muraki S., Oka H., Tanaka S., Kawaguchi H., Nakamura K., et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage [Internet] 2012 Jul 12, [cited 2012 Jul 17].
47. Hoeven T.A., Kavousi M., Clockaerts S., Kerkhof H.J., van Meurs J.B., Franco O., et al. Association of atherosclerosis with presence and progression of osteoarthritis: the Rotterdam study. Ann Rheum Dis 2012 May 6, [Epub ahead of print].
48. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
49. Deng Y., Scherer P.E. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010 Nov, 1212:E1-E19.
50. Yusuf E., Ioan-Facsinay A., Bijsterbosch J., Klein-Wieringa I., Kwekkeboom J., Slagboom P.E., et al. Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann Rheum Dis 2011 Jul, 70(7):1282-1284.
51. Filková M., LiŠková M., Hulejová H., Haluzík M., Gatterová J., Pavelková A., et al. Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis. Ann Rheum Dis 2009 Feb 1, 68(2):295-296.
52. de Boer T.N., van Spil W.E., Huisman A.M., Polak A.A., Bijlsma J.W.J., Lafeber F.P.J.G., et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage 2012 Aug, 20(8):846-853.
53. Clockaerts S., Bastiaansen-Jenniskens Y.M., Runhaar J., Van Osch G.J.V.M., Van Offel J.F., Verhaar J.A.N., et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage 2010 Jul, 18(7):876-882.
54. Distel E., Cadoudal T., Durant S., Poignard A., Chevalier X., Benelli C. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum 2009 Nov, 60(11):3374-3377.
55. Busso N., Karababa M., Nobile M., Rolaz A., Van Gool F., Galli M., et al. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS ONE 2008 May 21, 3(5):e2267.
56. Richette P., Poitou C., Garnero P., Vicaut E., Bouillot J.L., Lacorte J.M., et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann Rheum Dis 2011 Jan, 70(1):139-144.
57. Kyrkanides S., Tallents R.H., Miller J.-N.H., Olschowka M.E., Johnson R., Yang M., et al. Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice. J Neuroinflammation 2011, 8:112.
58. Licastro F., Candore G., Lio D., Porcellini E., Colonna-Romano G., Franceschi C., et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005 May 18, 2(1):8.
59. Loeser R.F. Aging and osteoarthritis. Curr Opin Rheumatol 2011 Sep, 23(5):492-496.
60. Coppé J.-P., Desprez P.-Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010, 5:99-118.
61. Campisi J., Andersen J.K., Kapahi P., Melov S. Cellular senescence: a link between cancer and age-related degenerative disease?. Semin Cancer Biol 2011 Dec, 21(6):354-359.
62. Forsyth C.B., Cole A., Murphy G., Bienias J.L., Im H.-J., Loeser R.F. Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. J Gerontol A Biol Sci Med Sci 2005 Sep, 60(9):1118-1124.
63. Lotz M., Loeser R.F. Effects of aging on articular cartilage homeostasis. Bone 2012 Aug, 51(2):241-248.
64. Loeser R.F., Yammani R.R., Carlson C.S., Chen H., Cole A., Im H.-J., et al. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum 2005 Aug, 52(8):2376-2385.
65. Rasheed Z., Akhtar N., Haqqi T.M. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-B in human osteoarthritis chondrocytes. Rheumatology 2010 Dec 20, 50(5):838-851.
66. Tankó L.B., Søndergaard B.-C., Oestergaard S., Karsdal M.A., Christiansen C. An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage. Climacteric 2008 Feb, 11(1):4-16.
67. Richette P., Dumontier M.-F., Tahiri K., Widerak M., Torre A., Benallaoua M., et al. Oestrogens inhibit interleukin 1beta-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-kappa B impairment. Ann Rheum Dis 2007 Mar, 66(3):345-350.
68. Pfeilschifter J., Köditz R., Pfohl M., Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002 Feb, 23(1):90-119.
69. Guilak F. Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheumatol 2011 Dec, 25(6):815-823.
70. Issa R.I., Griffin T.M. Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation. Pathobiol Aging Age Relat Dis [Internet] 2012 May 9, 2. [cited 2012 Jul 18].
71. Stevens A.L., Wishnok J.S., White F.M., Grodzinsky A.J., Tannenbaum S.R. Mechanical injury and cytokines cause loss of cartilage integrity and upregulate proteins associated with catabolism, immunity, inflammation, and repair. Mol Cell Proteomics 2009 Jul, 8(7):1475-1489.
72. Chauffier K., Laiguillon M.-C., Bougault C., Gosset M., Priam S., Salvat C., et al. Induction of the chemokine IL-8/Kc by the articular cartilage: possible influence on osteoarthritis. Joint Bone Spine [Internet] 2012 Feb 15, [cited 2012 Jul 17].
73. Gosset M., Berenbaum F., Levy A., Pigenet A., Thirion S., Saffar J.-L., et al. Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene. Arthritis Res Ther 2006, 8(4):R135.
74. Sanchez C., Pesesse L., Gabay O., Delcour J.-P., Msika P., Baudouin C., et al. Regulation of subchondral bone osteoblast metabolism by cyclic compression. Arthritis Rheum 2012 Apr, 64(4):1193-1203.
75. Berenbaum F. Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol 2004 Sep, 16(5):616-622.
76. Verbruggen G., Wittoek R., Vander Cruyssen B., Elewaut D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis 2012 Jun, 71(6):891-898. [Epub 2011 Nov 29].
77. Chevalier X., Goupille P., Beaulieu A.D., Burch F.X., Bensen W.G., Conrozier T., et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009 Mar 15, 61(3):344-352.
78. Maksymowych W.P., Russell A.S., Chiu P., Yan A., Jones N., Clare T., et al. Targeting tumor necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther 2012 Oct 4, 14(5):R206.